Mastocytosis is a rare disease characterised by expansion and collection of clonal mast cells in various organs including the skin, bone marrow, spleen, lymph nodes and gastrointestinal tract. The prevalence of mastocytosis has been estimated to be one in 10 000, while the estimated incidence is one per 100 000 people per year. Cutaneous mastocytosis is classified into (i) maculopapular cutaneous mastocytosis, also known as urticaria pigmentosa; (ii) diffuse cutaneous mastocytosis; and (iii) mastocytoma of the skin. In adults, cutaneous lesions are usually associated with indolent systemic mastocytosis and have a chronic evolution. Paediatric patients, on the contrary, have often cutaneous manifestations without systemic involvement and usually experience a spontaneous regression. Diagnosis of cutaneous mastocytosis may be challenging due to the rarity of the disease and the overlap of cutaneous manifestations. This short review describes pathogenesis and clinical aspects of cutaneous mastocytosis with a focus on diagnosis and currently available therapies.

Di Raimondo, C., Del Duca, E., Silvaggio, D., Di Prete, M., Lombardo, P., Mazzeo, M., et al. (2021). Cutaneous mastocytosis: a dermatological perspective. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 62(1) [10.1111/ajd.13443].

Cutaneous mastocytosis: a dermatological perspective

Spallone, Giulia;Campione, Elena;Botti, Elisabetta;Bianchi, Luca
2021-02-01

Abstract

Mastocytosis is a rare disease characterised by expansion and collection of clonal mast cells in various organs including the skin, bone marrow, spleen, lymph nodes and gastrointestinal tract. The prevalence of mastocytosis has been estimated to be one in 10 000, while the estimated incidence is one per 100 000 people per year. Cutaneous mastocytosis is classified into (i) maculopapular cutaneous mastocytosis, also known as urticaria pigmentosa; (ii) diffuse cutaneous mastocytosis; and (iii) mastocytoma of the skin. In adults, cutaneous lesions are usually associated with indolent systemic mastocytosis and have a chronic evolution. Paediatric patients, on the contrary, have often cutaneous manifestations without systemic involvement and usually experience a spontaneous regression. Diagnosis of cutaneous mastocytosis may be challenging due to the rarity of the disease and the overlap of cutaneous manifestations. This short review describes pathogenesis and clinical aspects of cutaneous mastocytosis with a focus on diagnosis and currently available therapies.
feb-2021
Pubblicato
Rilevanza internazionale
Review
Esperti anonimi
Settore MED/35 - MALATTIE CUTANEE E VENEREE
Settore MEDS-10/C - Malattie cutanee e veneree
English
cutaneous malignancies; cutaneous mastocytosis; mastocytosis; urticaria pigmentosa
Di Raimondo, C., Del Duca, E., Silvaggio, D., Di Prete, M., Lombardo, P., Mazzeo, M., et al. (2021). Cutaneous mastocytosis: a dermatological perspective. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 62(1) [10.1111/ajd.13443].
Di Raimondo, C; Del Duca, E; Silvaggio, D; Di Prete, M; Lombardo, P; Mazzeo, M; Spallone, G; Campione, E; Botti, E; Bianchi, L
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
10.1111@ajd.13443-1 mastocytosis.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 1.63 MB
Formato Adobe PDF
1.63 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/255354
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 12
social impact